Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota

Sanjiv Singh Rawat; Nigam P Narain; Sanjay M Marathe; Sourabh B Sonawale; Krishna C Veligandla

doi:10.7759/cureus.36795

Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota

Cureus. 2023 Mar 28;15(3):e36795. doi: 10.7759/cureus.36795. eCollection 2023 Mar.

Authors

Sanjiv Singh Rawat¹, Nigam P Narain², Sanjay M Marathe³, Sourabh B Sonawale⁴, Krishna C Veligandla⁴

Affiliations

¹ Pediatrics, Child Care Hospital, Indore, IND.
² Pediatrics, Patna Medical College, Patna, IND.
³ Pediatrics, Colours Pediatrics Intensive Care and Neonatal Care Hospital, Nagpur, IND.
⁴ Medical Affairs, Dr. Reddy's Laboratories, Hyderabad, IND.

Abstract

This study aimed to review the existing literature to investigate the potential link between early-life antibiotic use and being overweight or obese in children. PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library were searched to identify studies published until August 2021 that assessed the relationship between early-childhood antibiotic use and measures of body mass index. The studies included children aged 0-18 years. Only cohort studies were taken into consideration. Studies published in languages other than English were excluded. Antibiotic usage in early life may increase the risk of obesity in children and the addition of yeast probiotics, such as Saccharomyces boulardii CNCM I 745, to antibiotic prescription can serve as a potential option to mitigate this risk.

Keywords: antibiotics; children; gut microbiome; obesity; overweight.

Publication types

Review